WASHINGTON (dpa-AFX) - Below are the earnings highlights for Nektar Therapeutics (NKTR):
-Earnings: -$125.52 million in Q2 vs. -$80.00 million in the same period last year. -EPS: -$0.69 in Q2 vs. -$0.45 in the same period last year. -Analysts projected -$0.74 per share -Revenue: $28.33 million in Q2 vs. $48.85 million in the same period last year.
Copyright RTT News/dpa-AFX